Johnson & Johnson seeks permission for phase-3 trial of its single-shot Covid-19 vaccine in India, import license
NEW DELHI: Multinational pharma giant Johnson & Johnson has applied to India's drug regulator seeking permission to conduct phase-3 clinical...
